Data protection Impressum

Biotech

Swiss start-ups raised CHF 1.47 billion in the first half of 2025, with biotech and fintech driving growth despite fewer deals and cautious investor sentiment.

Business environment

Swiss start-ups attract CHF 1.47 billion in first half of 2025

15 July 2025

Neuchâtel, renowned globally for its watchmaking heritage, has evolved into a dynamic hub of cutting-edge innovation. Today, the canton leverages its tradition of precision craftsmanship to excel in fields as diverse as blockchain, quantum technology, renewable energy, life sciences, and advanced manufacturing. The canton of Neuchâtel’s transformation highlights its unique ability to merge historical excellence with visionary innovation, positioning itself as a leading force within Switzerland’s economic landscape.

Neuchâtel, a legacy of precision driving tomorrow’s innovation

Geneva-based biotech Stalicla secures funding to advance precision medicine programs for autism and substance use disorders.

Addex Therapeutics leads CHF 2 million investment in Stalicla

14 July 2025

Biopôle adds 18 new private labs for life sciences scale-ups in Lausanne, offering flexible, plug-and-play infrastructure in the new Trypto building.

Biopôle expands with 18 new private laboratories for life sciences scale-ups

2 July 2025

Two high-potential start-ups from Western Switzerland, HAYA Therapeutics and Neural Concept, have been named among the World Economic Forum’s 100 Technology Pioneers of 2025.

Two Lausanne-based start-ups named WEF Technology Pioneers in 2025

30 June 2025

ADM is strengthening its innovation footprint in Western Switzerland with a new R&D center focused on microbiomes to support animal health. The center is located at the Biopôle in Lausanne.

ADM opens new R&D center at Biopôle to advance animal microbiome science

30 June 2025

Superlab Suisse will open a new laboratory at Campus Biotech in Geneva in January 2026, strengthening the region’s innovation infrastructure for life sciences start-ups.

Superlab expands to Geneva with new lab at Campus Biotech

25 June 2025

Launched in Hamburg, the ORYL F1 marks a new milestone for EPFL spin-off ORYL Photonics, combining speed, precision, and sustainability for drug development.

ORYL Photonics launches breakthrough solubility and aggregation measurement platform

24 June 2025

Biotech KYLYS Aesthetics has raised CHF 1 million to advance clinical development of its next-generation hyaluronic acid medical devices for regenerative aesthetic medicine.

Geneva-based KYLYS raises CHF 1 million to advance regenerative aesthetic medicine

23 June 2025

At the crossroads of tradition and innovation, the University of Fribourg’s Section of Medicine offers a distinct vision for the future of healthcare. As part of Switzerland’s only fully bilingual university, the Section of Medicine is advancing both education and translational research in a collaborative, human-focused environment.

The University of Fribourg’s human-centered approach to medicine

1 2 3 4 5 … 22